Paul Krawitz

New Research Reveals Stunning Facts on Macular Degeneration in Women



Posted: Wednesday, August 20, 2008

by
Vitamin Science Inc

Previous research showed that women have a higher risk for Age-related Macular Degeneration (AMD). Gender is a definitive risk factor for AMD, according to the National Eye Institute , with women having a higher preponderance of the disease.

A new study has unveiled why women have an increased risk for AMD, and how hormone replacement therapy reduces that risk.

According to the study, estrogen (a hormone that helps in the development and maintenance of female characteristics) becomes deficient in women after menopause, and this deficiency makes women more likely to suffer AMD. The study suggests that hormone replacement therapy in women after menopause can help cut the risk of wet macular degeneration, but what is unexpected is that this therapy also increases the risk of dry AMD in women.

The findings of this study reinforce the effectiveness of nutritional therapy for the prevention of AMD in women, because treatment with nutritional supplements is not only effective in reducing the risk of the disease, it's also substantially safer than hormone replacement therapy.

The study: Facts and Findings

The study, entitled Menopausal and Reproductive Factors and Risk of Age-Related Macular Degeneration , was published in the April 2008 issue of the professional journal Archives of Ophthalmology .

The researchers looked at the Nurses' Health Study, and noted--in 74,996 postmenopausal women--certain factors related to estrogen, as for example, past use of oral contraceptive medicines, postmenopausal hormone replacement therapy, and so on. They noted that 554 of the women developed early or dry AMD and 334 developed more advanced or wet AMD.

The researchers found that the risk for wet or advanced AMD was 48% lower in women who received hormone replacement therapy after their menopause. However, there was a 34% increase in the risk for early or dry AMD in women who received hormone replacement therapy, an unexpected negative adverse result.

The study has therefore unveiled that hormone therapy in postmenopausal women reduces the risk of advanced or wet AMD, but it can also cause a substantial increase in the risk of early or dry AMD.

What's Important in this Study

The researchers suggested that oxidative stress plays an important role in the degeneration of retina's epithelium. In women, estrogen may have a protective role against the oxidative stress on the retina and thus this hormone helps promote the survival of the retina's epithelium. According to the researchers, various compounds of estrogen work as potent antioxidants, and act against oxidative stress.

Therefore, it becomes evident from this study that after menopause in women, there is a deficiency in estrogen, and this in turn suggests that there is deficiency in antioxidants in postmenopausal women. This antioxidant deficiency increases the oxidative stress on the retina, and thus women after menopause become prone to AMD.

What's Next

In postmenopausal women, when hormone replacement therapy lacks safety, nutritional therapy seems to be a justified option in reducing the risk of AMD.

Nutritional supplements act as scavengers of free radicals, thus reducing the oxidative damage to the retina; and advocating these supplements is safer compared to other treatment options, such as hormone replacement therapy.

Apart from that, other risk factors for AMD--cigarette smoking, obesity, heart disease etc-should also be taken care of, because working on these factors is important for reducing the risk of AMD in women.

Nutritional Supplements: They Fight for You

Nutrients, with their antioxidant properties, can fight against oxidative stress and reduce the risk of AMD in woman. Additional studies substantiating the benefit of nutritional supplements to treat macular degeneration include these:



Ophthalmologist  Dr. Paul Krawitz founded VisiVite.com in 2001. VisiVite publishes pertinent eye health information, such as  http://www.visivite.com/macular-degeneration-explained.html and additionally provides customers with state-of-the-art macular degeneration vitamins.

This Article has been viewed 988 times. (Not updated in real-time.)
No comments yet.
We want your comments! If you can read this, you don't have javascript enabled, so you can't use this comment system. Please enable javascript.